Biotech Q&A: President of Q BioMed Inc. (OTCQB: QBIO) Expands on Corporate Update

Denis Corin Discusses Mannin Research Inc’s Leading Glaucoma Drug Candidate MAN-01

March 21, 2016 Point Roberts WA - Investorideas.com, a digital global news source covering leading sectors including medical technology and biotech stocks releases a recent interview with Mr. Denis Corin, President of Q BioMed Inc. (OTCQB: QBIO).  Denis expands on the recent corporate update and Scrip ... Read more

Glaucoma Companies Aerie (Nasdaq:AERI), Glaukos (NYSE:GKOS), Q BioMed (OTCQB:QBIO), Inotek (Nasdaq:ITEK), NicOx SA (Paris: COX.PA) Approach a Devasting Disease with  a Variety of Treatments

New York, NY; Pt, Roberts, WA - April 7, 2016- Investorideas.com, a digital global news source covering leading sectors including medical technology and biotech stocks releases the following report on Glaucoma and public companies ... Read more

Q BioMed (OTCQB: QBIO) News: Mannin Research to Present Glaucoma Therapeutics Treatment at MedCity INVEST Chicago

Management to Present Lead drug candidate to Industry and Venture Finance Executives

NEW YORK - April 12, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company is pleased to announce that its ... Read more